483 Roundup: Four Firms Called Out Over Quality, Sanitation Concerns

Drug GMP Report
A A
The FDA issued Form 483s to U.S. and foreign drugmakers, citing violations for sanitation issues, unreliable data and nonconformances, among other observations.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $200.00